Linaclotide

The day before news had broken that Forest would seek approval for a new application of one of its drugs, Linaclotide.

Bearish Calls: Two Analysts Get Shunned Over Their Views John Jannarone 2010

Linaclotide later turned out to be successful, but other analysts say such a change in trial plans sometimes precedes failure.

Bearish Calls: Two Analysts Get Shunned Over Their Views John Jannarone 2010

Linaclotide, an investigational drug, is an agonist of the guanylate cyclase type-C GC-C receptor located on the luminal surface of the intestine.

unknown title 2011

Linaclotide's approval would be a major boost for Forest Labs.

unknown title 2011

Linaclotide, Ironwood's GC-C agonist, is an investigational drug for the treatment of irritable bowel syndrome with constipation IBS-C and chronic constipation.

unknown title 2011

Linaclotide, Ironwood's GC-C agonist, is an investigational drug for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC).

unknown title 2012

Linaclotide, Ironwood's GC-C agonist, is in Phase 3 clinical development for the treatment of irritable bowel syndrome with constipation IBS-C and chronic constipation.

unknown title 2011

Linaclotide, Ironwood's GC-C agonist, is in Phase 3 clinical development for the treatment of irritable bowel syndrome with constipation IBS-C and chronic constipation.

unknown title 2011

Linaclotide, Ironwood's GC-C agonist, is an investigational drug for the treatment of irritable bowel syndrome with constipation IBS-C and chronic constipation.

unknown title 2011

Ironwood Pharmaceuticals, Inc. InPlay: Ironwood Pharma announced last night FDA Advisory committee meeting will not be scheduled in connection with new drug application for Linaclotide

unknown title 2012